Leading by example

Board of Directors

Chairman & Managing Director
Glenn Saldanha
+
Chairman & Managing DirectorGlenn Saldanha

Glenn Saldanha is the Chairman & Managing Director of Glenmark Pharmaceuticals Limited. He joined Glenmark Pharmaceuticals in 1998 as Director and took over as Managing Director & CEO in 2001.

As Chairman & Managing Director of Glenmark Pharmaceuticals Limited, Glenn Saldanha oversees all operations of the organization. During his tenure, he transformed Glenmark into a truly global organization with revenue over a billion dollar and commercial presence in over 80 countries. Under his leadership, Glenmark has evolved from an Indian branded generics business, into a research-driven and innovation-led organization. Glenn's vision is to discover, develop and take to market India's first innovative drug for the entire world. 

Glenn holds a Bachelor’s Degree in Pharmacy from Mumbai University and is an MBA from the Leonard Stern School of Business at New York University. Prior to Glenmark, he has worked with Eli Lily, USA and PriceWater House Coopers, USA.

Executive Director
Rajesh V Desai
+
Executive DirectorRajesh V Desai

Mr. Rajesh V. Desai is the Chief Financial Officer of Glenmark and has been with the organization for close to 30 years. A member of the leadership team for over a decade, he heads the Finance, and Legal & IT function of the entire organization. Mr. Desai has been responsible for charting company's growth in domestic and overseas markets in the past.

Mr. Desai holds a Bachelors Degree in Science (B.Sc.) from the Bombay University and is a Chartered Accountant from Institute of Chartered Accountants of India (ICAI).

Director – Corporate Affairs
Cherylann Pinto
+
Director – Corporate AffairsCherylann Pinto

Ms. Cherylann Pinto is an executive member of the Board of Directors and is one of the promoters of Glenmark Pharmaceuticals Ltd. She has over 28 years pharma industry experience and has been associated with Glenmark since 1999. As Director - Corporate Affairs, she heads Glenmark’s Human Resource, Corporate Communications, Corporate Social Responsibility and Corporate Affairs functions. Prior to her association with Glenmark, Ms. Pinto had founded a pharmaceutical company where she was the Managing Director for 10 years.

Glenmark’s CSR initiatives under her leadership in the area of Child Health, reducing malnutrition & infant mortality, improving medicine access and providing sustainable livelihood has been recognized by the Bombay Chambers of Commerce Award  2014 and the 5th Asia Best CSR Practices Award, where she also won the ‘Women Leadership Award’ in 2015.

Ms. Pinto holds a Bachelor’s Degree in pharmacy from the Institute of Chemical Technology (ICT) in Mumbai and has also completed The General Management Program from the Harvard Business School in Boston.

Non-Executive Director
Brian W Tempest
+
Non-Executive DirectorBrian W Tempest

Dr. Brian W. Tempest is the Editor of the Journal of Generic Medicines. He is also a Non-Executive Director on the Governance Board of the United Nations Patent Pool. Previously he worked for Ranbaxy Laboratories since 1995 holding the position of Managing Director and Chief Executive Officer until 2005. He was then Chief Mentor and Non-Executive Director until 2008.

Dr. Tempest has also worked for Glaxo as Regional Director Far East and Regional Director Middle East & Africa from 1985 to 1992. He has worked in the Pharmaceutical Industry for the last 45 years and has managed Healthcare businesses in North America, South America, Europe, Africa, Middle East, Australasia, China, Japan and India.

Dr. Tempest is now a Non-Executive Director of Religare Capital Markets, Fortis Healthcare, SRL Diagnostics and Petainer-Innopac. He is a member of the SCRIP Global awards panel. He is also an international advisor to UNCTAD and MAPE, an Indian M&A boutique. Dr. Tempest has a PhD in Polymer Chemistry from Lancaster University and a D.Sc. (Hon) from Aston University, UK. In 2009 he became Chairman of the Advisory Board for the Lancaster University Management School, UK. He is a Fellow of the Royal Society of Medicine, a Fellow of the Royal Society of Chemistry and is a Chartered Chemist.

Non-Executive Director
Bernard Munos
+
Non-Executive DirectorBernard Munos

Mr.Bernard Munos is a Senior Fellow at FasterCures, a center of the Milken Institute. His research on pharmaceutical innovation has been published in Nature and Science, as well as profiled by Forbes magazine. The popular industry newsletter FiercePharma has named him one of the 25 most influential people in biopharma. 

Mr. Munos advises organizations on being better innovators. He serves on the Advisory Council of the National Center for Advancing Translational Sciences (NCATS); is a member of the National Academy of Medicine's Forum on Drug R&D and Translation; an Advisor to the journal Science Translational Medicine; and an Advisor to or Board member of multiple companies and publicly-financed research organizations.

Mr. Munos has discussed his research at numerous meetings sponsored by the President's Cancer Panel, the NIH Leadership Forum, the FDA, the World Health Organization, the OECD, the New York Academy of Sciences, the Brookings Institution, the Kauffman Foundation, the US Patent and Trademark Office, the American Chemical Society, as well as leading universities in the US, Europe, and Asia. He also blogs about innovation for Forbes and FastCures.

Mr. Munos received his MBA from Stanford University, and holds other graduate degrees from University of California at Davis, and the Paris Institute of Technology for Life, Food and Environmental Sciences in France. 

Non-Executive Director
Blanche E. Saldanha
+
Non-Executive DirectorBlanche E. Saldanha

Mrs. Blanche E. Saldanha is a Non-Executive Director and a member of the promoter group of Glenmark Pharmaceuticals Limited. Prior to this position, Mrs. Saldanha was the Director – Exports and managed Glenmark’s international operations from 1982 to 2005. During her 23 year tenure with the organization, she was responsible for developing and growing the company’s export business.

Mrs. Saldanha holds a Bachelors Degree in Science (B.Sc.) and a Bachelors Degree in Education (B.Ed.) from Bombay University.

Non-Executive Director
Julio Ribeiro
+
Non-Executive DirectorJulio Ribeiro

Mr. Julio Ribeiro has been associated with Glenmark since 1999. He is a retired Indian police officer & civil servant and has held increasingly responsible positions during his career. Some of the noteworthy positions include - the Commissioner of Police, Mumbai; Special Secretary to Government of India, Ministry of Home Affairs; Director General of Police, Punjab; Adviser to the Governor of Punjab and Ambassador of India to Romania.

Mr. Ribeiro was conferred with the Padma Bhushan, India's third highest civilian award for his services in 1987. He served as an Independent Director of Fullerton India Credit Company Limited until 2011 and currently serves as Director of VVF Ltd. Mr. Ribeiro holds a Bachelors degree in Commerce and a Bachelors degree in Law from the Bombay University.

Non-Executive Director
Sridhar Gorthi
+
Non-Executive DirectorSridhar Gorthi

Mr. Sridhar Gorthi is a partner in the Mumbai office of Trilegal and his areas of expertise include M&A, joint ventures, private equity and venture capital. He has been actively involved in several high profile cross-border transactions and is a leading member of Trilegal's corporate practice. Apart from representing a number of international clients on M&A in India, Mr. Gorthi has also advised Indian companies in connection with outbound M&A transactions in jurisdictions such as the UK, USA, South Africa, Argentina, Indonesia and Sri Lanka.

Mr. Gorthi has been named one of the leading lawyers in India for Mergers & Acquisitions, Private Equity and Venture Capital in India by the Guide to Asia Pacific’s Leading Lawyers 2010, 2011 and 2012; and by IFLR 1000, 2011 and 2012.

Non-Executive Director
Milind Sarwate
+
Non-Executive DirectorMilind Sarwate

Mr. Milind Sarwate is the Founder and CEO of Increate Value Advisors LLP, a firm that facilitates organizations and individuals to discover, develop and deliver business & social value. He has over 32 years of experience in Finance, HR and Strategy in groups like Marico & Godrej.

Mr. Sarwate has received the ICAI Award - CFO - FMCG 2011, CNBC TV-18 Best Performing CFO Award -FMCG & Retail-2012 and was also included in the CFO India Hall of Fame 2013 by CFO India magazine. 

He is a Chartered Accountant, Cost Accountant & Company Secretary, holds a Bachelors degree in Commerce (B.Com Hons.) from the Bombay University and a CII-Fulbright Fellow (Carnegie Mellon University, Pittsburgh, PA, USA).

Non-Executive Director
D R Mehta
+
Non-Executive DirectorD R Mehta

Mr. D.R. Mehta joined the Indian Administrative Service in 1961 and held numerous important positions initially in the Government of Rajasthan and later in the Government of India. He has served as Chairman of SEBI, the Deputy Governor of the RBI, the Director General of Foreign Trade, Ministry of Commerce and Government of India. He was also the Controller of Capital Issues, Additional Secretary Banking in the Ministry of Finance in Government of India.  

Mr. Mehta is the founder and chief patron of Bhagwan Mahaveer Viklang Sahayata Samiti (BMVSS) Jaipur, the world's largest organization for the rehabilitation of the handicapped. He was conferred with the Padma Bhushan in 2008 and the Rajiv Gandhi National Sadbhavana Award in 2012. Mr. Mehta holds a Bachelors Degree in Arts and an LLB degree from the Rajasthan University. He also holds Management Degrees from Royal Institute of Public Administration, London and Alfred Sloan School of Management, MIT, Boston, US.

Founder Emeritus

Late Mr. Gracias Saldanha

"Glenmark has been built on the pillars of Integrity, Knowledge, Trust & Respect"